Search hospitals > California > San Rafael
Kaiser Permanente-San Rafael
Claim this profileSan Rafael, California 94903
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Pancreatic Cancer
Conducts research for Colon Cancer
150 reported clinical trials
4 medical researchers
Summary
Kaiser Permanente-San Rafael is a medical facility located in San Rafael, California. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Pancreatic Cancer, Colon Cancer and other specialties. Kaiser Permanente-San Rafael is involved with conducting 150 clinical trials across 286 conditions. There are 4 research doctors associated with this hospital, such as Jennifer M. Suga, Tatjana Kolevska, MD, Samantha A. Seaward, and Ramey D. Littell.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
ER positive
PR positive
2Lung Cancer
Global LeaderStage I
Stage II
Stage III
Top PIs
Jennifer M. SugaKaiser Permanente-Oakland2 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
38 reported clinical trials
103 drugs studied
Tatjana Kolevska, MDKaiser Permanente-Vallejo2 years of reported clinical research
Studies Cancer
Studies Melanoma
22 reported clinical trials
52 drugs studied
Samantha A. SeawardKaiser Permanente Medical Center - Santa Clara3 years of reported clinical research
Studies Breast Cancer
Studies Prostate Cancer
22 reported clinical trials
63 drugs studied
Ramey D. LittellKaiser Permanente-Roseville5 years of reported clinical research
Studies Ovarian Cancer
Studies Fallopian Tube Cancer
5 reported clinical trials
13 drugs studied
Clinical Trials running at Kaiser Permanente-San Rafael
Lung Cancer
Brain Tumor
Cardiotoxicity
Breast cancer
ALK Gene Rearrangement
Meningioma
Cutaneous Melanoma
Breast Cancer
Brain Metastasis
HER2 Positive
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Kaiser Permanente-San Rafael?
Kaiser Permanente-San Rafael is a medical facility located in San Rafael, California. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Pancreatic Cancer, Colon Cancer and other specialties. Kaiser Permanente-San Rafael is involved with conducting 150 clinical trials across 286 conditions. There are 4 research doctors associated with this hospital, such as Jennifer M. Suga, Tatjana Kolevska, MD, Samantha A. Seaward, and Ramey D. Littell.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.